Revanesse Versa

Category Name	Content
Name	Revanesse Versa (Hyaluronic Acid Dermal Filler)
Uses	FDA-approved for moderate to severe facial wrinkles and folds, including nasolabial folds. Off-label uses include lip augmentation, tear trough correction, and jawline contouring.
Route of Administration	Intradermal or subdermal injection.
Frequency of Use	Maximum every 3 months for elective patients. Effects last approximately 6–12 months.
Concentration(s)	20 mg/mL of cross-linked hyaluronic acid.
Maximum Dosage	Max 2.0 mL per session. Max 4.0 mL per 3-month period.
Contraindications	• Pregnancy, breastfeeding, or planning pregnancy. • Allergy to hyaluronic acid or lidocaine. • History of severe allergies, anaphylaxis, or autoimmune conditions. • Active skin infections, acne, or inflammation in the treatment area. • History of vascular occlusion, necrosis, or embolism from previous procedures. • Use of blood thinners or immunosuppressive medications. • Patients under 22 years old (per FDA approval). • Patients undergoing allergy desensitization therapy.
Possible Side Effects	• Common: Swelling, bruising, tenderness, redness at injection sites. • Rare: Vascular occlusion, nodules, granulomas, hypersensitivity reactions. • Severe: Anaphylaxis, arterial embolization, tissue necrosis requiring surgical intervention.
Compatibility With Other Treatments/Drugs	• Safe with: Neuromodulators (Botox, Dysport), most dermal fillers. • Avoid with: Recent laser treatments, chemical peels, or other dermal fillers within the last 3 months.
Allergies	Patients allergic to hyaluronic acid, lidocaine, or undergoing allergy desensitization therapy should not receive treatment.
Administration Time	Injection procedure takes approximately 30–45 minutes, including preparation and aftercare.
Dosing/Settings	• Recommended starting dose: 0.5 mL per area, gradually increasing as needed. • Maximum 1.0 mL per side (cheeks, jawline) in a single session. • Use small bolus injections or linear threading technique for best results.
What To Do If Adverse Reaction Occurs	• Vascular occlusion: Stop injection immediately, apply warm compress, massage area, administer hyaluronidase if needed. • Anaphylaxis: Administer epinephrine (0.3 mg IM), call 911, provide airway support. • Granulomas: Refer to dermatology for corticosteroid or 5-FU treatment. • Necrosis: Immediate referral to a specialist for wound care and potential debridement.
Additional Documentation Requirements	• Signed informed consent form. • Pre-treatment photos (frontal and side views). • Medical clearance if history of vascular complications, autoimmune disease, or recent oncology treatment. • Documentation of past filler treatments and allergy history.
Post-Treatment Care Instructions	• Avoid strenuous exercise, alcohol, and excessive sun exposure for 24 hours. • Apply cold compress if swelling or bruising occurs. • Do not manipulate or massage the treated area unless instructed by the provider. • Follow up in 2–4 weeks for reassessment and potential touch-up treatment if needed.